Posts Tagged 'actos'

Takeda to Go Forward with $2.3 Billion Actos Settlement

actos settlement set to move forwardEnough plaintiffs have joined the $2.3 billion Actos settlement, that Takeda Pharmaceuticals is going to proceed with the deal, FiercePharma reports. Last month it was unclear whether the Japan-based company would be able to attract enough plaintiffs by the September 11 deadline. But according to Takeda, 96% of Actos plaintiffs joined the settlement before the deadline. If that number rises to 97%, the company will increase the ...

continue reading...

Takeda’s $2.4 Billion Actos Settlement May Not Be Realized

takeda acts settlement may fall through for lack of plaintiffsAs reported by Bloomberg, Takeda Pharmaceutical’s proposed $2.37 billion Actos settlement may be in danger because not enough plaintiffs are signing on. The multibillion-dollar accord was reached back in April, when Takeda agreed to use the funds to settle the bulk of its 8,000 pending Actos lawsuits.

Actos is a best-selling hypoglycemic drug approved for treatment of type 2 diabetes. Takeda has been accused of ...

continue reading...

Takeda Agrees to Pay $2.4 Billion to Settle Actos Lawsuits

actos bladder cancer settlements to reach 2.4 billion dollarsAccording to a Reuters article, the multinational drug company Takeda Pharmaceutical has agreed to pay $2.4 billion to resolve the majority of its 8,000 Actos lawsuits. This represents a $200 million increase over the company’s initial settlement offer last month. Plaintiffs in Actos lawsuits allege that Takeda failed to warn doctors and patients that its Type II diabetes medication could increase the risk of bladder ...

continue reading...

Takeda Offers to Pay $2.2 Billion to Settle Actos Lawsuits

takeda has offered a settlement amount for actos bladder cancer lawsuitsBloomberg reports that the Japanese pharmaceutical company Takeda Pharmaceuticals has offered to pay $2.2 billion to resolve lawsuits claiming it hid bladder cancer risks associated with its diabetes drug Actos. If the settlement goes through, it will constitute one of the largest ever U.S. settlements over drug or device injury. Takeda seeks to settle over 8,000 Actos lawsuits pending in U.S. federal ...

continue reading...

Takeda Pharmaceuticals Accused of Neglecting Patient Safety in Actos Marketing

Unfortunately, pharmaceutical companies sometimes put profits ahead of all else. While it seems that patient safety should be at the forefront of a company’s efforts in drug development, some actions can raise questions as to a company’s true priorities. A recent Bloomberg article details the Philadelphia trial of a woman who claims the company marketed its diabetes drug Actos with little regard to patient safety. The plaintiff, who has developed cancer, claimed that the company failed to ...

continue reading...

Drug Maker Destroyed Evidence in Actos Bladder Cancer Lawsuit

Actos maker accused of destroying evidence in investigationA Louisiana judge has ruled in a bellwether trial that Takeda Pharmaceuticals destroyed evidence that would have helped the plaintiffs prove the company hid information about the cancer risks of its diabetes drug, Actos. The evidence was a part of a case that resulted in a $9 billion Actos verdict in April, 2014.

The April ruling was the first federal jury decision in a multidistrict litigation ...

continue reading...